Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma

被引:118
|
作者
Rosty, C
Sheffer, M
Tsafrir, D
Stransky, N
Tsafrir, I
Peter, M
de Crémoux, P
de La Rochefordière, A
Salmon, R
Dorval, T
Thiery, JP
Couturier, J
Radvanyi, F
Domany, E
Sastre-Garau, X
机构
[1] Inst Curie, Dept Biol Tumeurs, F-75248 Paris, France
[2] Inst Curie, CNRS, Oncol Mol UMR 144, F-75248 Paris, France
[3] Inst Curie, Dept Radiotherapy, F-75248 Paris, France
[4] Inst Curie, Dept Chirurg, F-75248 Paris, France
[5] Inst Curie, Dept Med Oncol, F-75248 Paris, France
[6] Inst Curie, Dept Tranfert, F-75248 Paris, France
[7] Weizmann Inst Sci, Dept Phys Complex Syst, Rehovot, Israel
关键词
cervical cancer; gene expression; HPV; prognosis; bioinformatics;
D O I
10.1038/sj.onc.1208854
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Specific HPV DNA sequences are associated with more than 90% of invasive carcinomas of the uterine cervix. Viral E6 and E7 oncogenes are key mediators in cell transformation by disrupting TP53 and RB pathways. To investigate molecular mechanisms involved in the progression of invasive cervical carcinoma, we performed a gene expression study on cases selected according to viral and clinical parameters. Using Coupled Two-Way Clustering and Sorting Points Into Neighbourhoods methods, we identified a 'cervical cancer proliferation cluster' composed of 163 highly correlated transcripts. Most of these transcripts corresponded to E2F pathway genes controlling cell division or proliferation, whereas none was known as TP53 primary target. The average expression level of the genes of this cluster was higher in tumours with an early relapse than in tumours with a favourable course (P = 0.026). Moreover, we found that E6/E7 mRNA expression level was positively correlated with the expression level of the cluster genes and with viral DNA load. These findings suggest that HPV E6/E7 expression level plays a key role in the progression of invasive carcinoma of the uterine cervix via the deregulation of cellular genes controlling tumour cell proliferation. HPV expression level may thus provide a biological marker useful for prognosis assessment and specific therapy of the disease.
引用
收藏
页码:7094 / 7104
页数:11
相关论文
共 50 条
  • [41] HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor
    Peng, Qiu
    Wang, Lujuan
    Zuo, Liang
    Gao, Shuichao
    Jiang, Xianjie
    Han, Yaqian
    Lin, Jinguan
    Peng, Mingjing
    Wu, Nayiyuan
    Tang, Yanyan
    Tian, Hao
    Zhou, Yujuan
    Liao, Qianjin
    CANCER GENE THERAPY, 2023, 31 (1) : 9 - 17
  • [42] Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin
    Milrot, Elad
    Jackman, Anna
    Kniazhanski, Tatiana
    Gonen, Pinhas
    Flescher, Eliezer
    Sherman, Levana
    CANCER LETTERS, 2012, 319 (01) : 31 - 38
  • [43] The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening
    Li, Bijun
    Guo, Ruixia
    Lai, Tianjiao
    Qiao, Long
    Fu, Hanlin
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (08) : 2720 - 2728
  • [44] RIPOR2 Expression Decreased by HPV-16 E6 and E7 Oncoproteins: An Opportunity in the Search for Prognostic Biomarkers in Cervical Cancer
    Olmedo-Nieva, Leslie
    Omar Munoz-Bello, J.
    Martinez-Ramirez, Imelda
    Daniel Martinez-Gutierrez, Antonio
    Ortiz-Pedraza, Yunuen
    Gonzalez-Espinosa, Claudia
    Madrid-Marina, Vicente
    Torres-Poveda, Kirvis
    Bahena-Roman, Margarita
    Lizano, Marcela
    CELLS, 2022, 11 (23)
  • [45] APOBEC3A possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer
    Chen, Shan
    Li, Xiao
    Qin, Junpu
    Chen, Yuan
    Liu, Longyang
    Zhang, Dongqing
    Wang, Minyi
    Wang, Maocai
    Zhang, Dikai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (07): : 10548 - 10557
  • [46] HPV types and E6/E7 mRNA expression in cervical samples from Turkish women with abnormal cytology in Ankara, Turkey
    Tuney, Ipek
    Altay, Aylin
    Ergunay, Koray
    Onder, Sevgen Celik
    Usubutun, Alp
    Salman, Mehmet Coskun
    Bozdayi, Gulendam
    Karabulut, Erdem
    Badur, Osman Selim
    Yuce, Kunter
    Pinar, Ahmet
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (01) : 194 - 200
  • [47] Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA
    Perez Castro, Sonia
    Inarrea Fernandez, Amparo
    Lamas Gonzalez, Maria Jose
    Saran Diez, Maria Teresa
    Cid Lama, Ana
    Alvarez Martin, Maria Jesus
    Pato Mosquera, Monica
    Lopez-Miragaya, Isabel
    Estevez, Nuria
    Torres Pinon, Julio
    Ona Navarro, Maria
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (06) : 1063 - 1068
  • [48] Analysis of E6/E7 mRNA gene expression by means of NucliSENS EasyQ (NASBA) technique in patients suffering from cervical dysplasia with HPV positive
    Ciplak, B.
    Yilmaz, E.
    Otlu, B.
    Coskun, E. I.
    Sahin, N.
    Tuncay, G.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (05) : 690 - 694
  • [49] Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers
    J T-C Chang
    T-F Kuo
    Y-J Chen
    C-C Chiu
    Y-C Lu
    H-F Li
    C-R Shen
    A-J Cheng
    Cancer Gene Therapy, 2010, 17 : 827 - 836
  • [50] Highly potent and specific siRNAs against E6 or E7 genes of HPV16-or HPV18-infected cervical cancers
    Chang, J. T-C
    Kuo, T-F
    Chen, Y-J
    Chiu, C-C
    Lu, Y-C
    Li, H-F
    Shen, C-R
    Cheng, A-J
    CANCER GENE THERAPY, 2010, 17 (12) : 827 - 836